Conexeu Sciences Inc. CNXU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.63M | -7.20M | -- | -- | -- |
| Total Depreciation and Amortization | 39.70K | 31.00K | -- | -- | -- |
| Total Amortization of Deferred Charges | 73.20K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.87M | 2.59M | -- | -- | -- |
| Change in Net Operating Assets | -2.88M | 233.70K | -- | -- | -- |
| Cash from Operations | -10.53M | -4.35M | -- | -- | -- |
| Capital Expenditure | -76.20K | -35.20K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.90K | -71.30K | -- | -- | -- |
| Cash from Investing | -107.10K | -106.50K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -92.20K | 3.90K | -- | -- | -- |
| Issuance of Common Stock | 9.35M | 10.82M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.75M | 857.00K | -- | -- | -- |
| Cash from Financing | 12.01M | 11.68M | -- | -- | -- |
| Foreign Exchange rate Adjustments | 3.50K | -3.90K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.38M | 7.22M | -- | -- | -- |